Issued Patents All Time
Showing 25 most recent of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12227482 | Compounds and compositions for the treatment of cancer | Bhairavi Tolani, Gavitt Woodard, Tsze H. Tsang, Michael J. Mann, David M. Jablons +1 more | 2025-02-18 |
| 12145925 | Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer | David M. Jablons, Tsze H. Tsang, Hassan Lemjabbar-Alaoui | 2024-11-19 |
| 11708352 | Anti-cancer compounds | David M. Jablons, Hassan Lemjabbar-Alaoui | 2023-07-25 |
| 11597699 | MEK inhibitors and methods of their use | Naing Aay, Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius +11 more | 2023-03-07 |
| 11560356 | Compounds and compositions for the treatment of cancer | Bhairavi Tolani, Gavitt Woodard, Tsze H. Tsang, Michael J. Mann, David M. Jablons +1 more | 2023-01-24 |
| 11149025 | Anti-cancer compounds | David M. Jablons, Hassan Lemjabbar-Alaoui | 2021-10-19 |
| 11072600 | Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer | David M. Jablons, Tsze H. Tsang, Hassan Lemjabbar-Alaoui | 2021-07-27 |
| 10640493 | Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer | David M. Jablons, Tsze H. Tsang, Hassan Lemjabbar-Alaoui | 2020-05-05 |
| 10562886 | Anti-cancer compounds | David M. Jablons, Hassan Lemjabbar-Alaoui | 2020-02-18 |
| 10266518 | Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof | Kenneth D. Rice, Neel K. Anand, Joerg Bussenius, Simona Costanzo, Abigail R. Kennedy +2 more | 2019-04-23 |
| 9796704 | Substituted quinazolines as receptor-type kinase inhibitors | Kenneth D. Rice, Neel K. Anand, Joerg Bussenius, Simona Costanzo, Abigail R. Kennedy +2 more | 2017-10-24 |
| 9359332 | Processes for the preparation of substituted quinazolines | Kenneth D. Rice, Neel K. Anand, Joerg Bussenius, Simona Costanzo, Abigail R. Kennedy +2 more | 2016-06-07 |
| 8697737 | Raf modulators and methods of use | Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius, Simona Costanzo +9 more | 2014-04-15 |
| 8658654 | Receptor-type kinase modulators and methods of use | Kenneth D. Rice, Neel K. Anand, Joerg Bussenius, Simona Costanzo, Abigail R. Kennedy +2 more | 2014-02-25 |
| 8648066 | Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture | Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Chris A. Buhr, Joerg Bussenius +14 more | 2014-02-11 |
| 8637499 | Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture | Naing Aay, Arlyn Arcalas, Joerg Bussenius, Steven Charles DeFina, Larisa Dubenko +9 more | 2014-01-28 |
| 8372851 | Pyrazolo pyrimidines as casein kinase II (CK2) modulators | Kenneth D. Rice, Joerg Bussenius, Simona Costanzo, Abigail R. Kennedy, Angie Inyoung Kim +1 more | 2013-02-12 |
| 8362002 | Azetidines as MEK inhibitors for the treatment of proliferative diseases | Naing Aay, Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius +11 more | 2013-01-29 |
| 8101625 | Pyrimidinones as Casein Kinase II (CK2) modulators | Kenneth D. Rice, Neel K. Anand, Arlyn Arcalas, Charles M. Blazey, Joerg Bussenius +12 more | 2012-01-24 |
| 8012956 | Tropane compounds | Kenneth D. Rice, Naing Aay, Neel K. Anand, Arlyn Arcalas, Tae-Gon Baik +15 more | 2011-09-06 |
| 7915250 | Azetidines as MEK inhibitors for the treatment of proliferative diseases | Naing Aay, Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius +11 more | 2011-03-29 |
| 7872014 | Anaplastic lymphoma kinase modulators and methods of use | Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius, Simona Costanzo +8 more | 2011-01-18 |
| 7846959 | Raf modulators and methods of use | Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius, Simona Costanzo +9 more | 2010-12-07 |
| 7803839 | Azetidines as MEK inhibitors for the treatment of proliferative diseases | Naing Aay, Neel K. Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius +11 more | 2010-09-28 |
| 7704995 | Protein kinase modulators and methods of use | Chris A. Buhr, Tae-Gon Baik, Sunghoon Ma, Zerom Tesfai, Longcheng Wang +23 more | 2010-04-27 |